Hjem › Uveal melanom › Pennsylvania
Uveal melanom kliniske forsøg i Pennsylvania
8 studier for Uveal melanom søger deltagere på steder i Pennsylvania.
Byer i Pennsylvania
Officiel studietekst (engelsk)
Study of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal Melanoma
- Wills Eye Hospital at Thomas Jefferson University, Philadelphia
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT07804186Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma
- UPMC Hillman Cancer Center, Pittsburgh
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT06070012Tebentafusp-tebn With LDT in Metastatic UM
- Thomas Jefferson University, Philadelphia
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 21. jul. 2026 · NCT06626516Neoadjuvant Tebentafusp for Uveal Melanoma
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 12. jun. 2026 · NCT06414590Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 8. jun. 2026 · NCT03947385ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
- University of Pennsylvania, Perelamn Center for Advanced Medicine, Philadelphia
- Thomas Jefferson University, Honickman Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
- og 1 flere
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 13. maj 2026 · NCT03686124Neoadjuvant Darovasertib in Primary Uveal Melanoma
- Jefferson Health Honickman Center, Philadelphia
- UPMC Hillman Cancer Center, Pittsburgh
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 6. maj 2026 · NCT07015190A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
- Thomas Jefferson University, Philadelphia
- UPMC Hillman Cancer Center, Pittsburgh
RekruttererFase 2/3
Alle aldre · Alle køn · Opdateret 2. apr. 2026 · NCT06581406Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.